Pancreatic Cancer Research

ResearcherHenry Ford HealthNo recent work listed

Subhash C. Gautam

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5111696142. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper

Papers 7

  1. The inhibition of cell proliferation and induction of apoptosis in pancreatic ductal adenocarcinoma cells by verrucarin A, a macrocyclic trichothecene, is asso… Last author DOI 10.3892/ijo.2016.3587↗
  2. CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma. Last author DOI 10.3892/ijo.2015.3212↗
  3. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells. Last author DOI 10.3892/or.2015.3989↗
  4. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling protei… Last author DOI 10.3892/ijo.2014.2325↗
  5. Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent. Last author DOI 10.3390/molecules18033250↗
  6. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of… Last author DOI 10.1016/j.bbrc.2012.05.024↗
  7. Inhibition of cell proliferation and induction of apoptosis by CDDO-Me in pancreatic cancer cells is ROS-dependent. Last author PMID 22946344↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dorrah Deeb · 7 shared papers, 2012–2016 · strength 0.36
  2. Xiaohua Gao · 7 shared papers, 2012–2016 · strength 0.36

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.